RA CAPITAL MANAGEMENT, L.P.
JANXRA CAPITAL MANAGEMENT, L.P. serves as director, 10 percent owner: at Janux Therapeutics, Inc. (JANX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
RA CAPITAL MANAGEMENT, L.P.'s Insider Trading at Janux Therapeutics, Inc. (JANX)
Buys
1 · $50.00M
Sells
0 · $0.00
Total Shares Bought
2,941,176
Total Shares Sold
0
RA CAPITAL MANAGEMENT, L.P.'s Insider Trading at Jade Biosciences, Inc. (JBIO)
Buys
1 · $39.00M
Sells
0 · $0.00
Total Shares Bought
2,785,714
Total Shares Sold
0
RA CAPITAL MANAGEMENT, L.P.'s Insider Trading at PepGen Inc. (PEPG)
Buys
1 · $38.75M
Sells
0 · $0.00
Total Shares Bought
3,229,200
Total Shares Sold
0
RA CAPITAL MANAGEMENT, L.P.'s Insider Trading at Nkarta, Inc. (NKTX)
Buys
1 · $33.00M
Sells
0 · $0.00
Total Shares Bought
2,200,000
Total Shares Sold
0
RA CAPITAL MANAGEMENT, L.P.'s Insider Trading at Werewolf Therapeutics, Inc. (HOWL)
Buys
2 · $31.57M
Sells
0 · $0.00
Total Shares Bought
2,038,298
Total Shares Sold
0
RA CAPITAL MANAGEMENT, L.P.'s Insider Trading at Phathom Pharmaceuticals, Inc. (PHAT)
Buys
0 · $0.00
Sells
1 · $31.06M
Total Shares Bought
0
Total Shares Sold
710,000
RA CAPITAL MANAGEMENT, L.P.'s Insider Trading at Acumen Pharmaceuticals, Inc. (ABOS)
Buys
1 · $30.00M
Sells
0 · $0.00
Total Shares Bought
1,875,000
Total Shares Sold
0
RA CAPITAL MANAGEMENT, L.P.'s Insider Trading at Tyra Biosciences, Inc. (TYRA)
Buys
1 · $20.00M
Sells
0 · $0.00
Total Shares Bought
1,250,000
Total Shares Sold
0
RA CAPITAL MANAGEMENT, L.P.'s Insider Trading at Solid Biosciences Inc. (SLDB)
Buys
1 · $12.69M
Sells
0 · $0.00
Total Shares Bought
2,206,685
Total Shares Sold
0
RA CAPITAL MANAGEMENT, L.P.'s Insider Trading at KALA BIO, Inc. (KALA)
Buys
0 · $0.00
Sells
1 · $1.49M
Total Shares Bought
0
Total Shares Sold
2,829,314
Showing 51–61 of 61
Related Insiders
Elizabeth Bhatt
President and COO
Fred Aslan
President and CEO
Jennifer Bush
officer: COO, CLO, Compliance Officer
Subhashis Banerjee
officer: Chief Medical Officer
Christopher Horan
officer: Chief Tech Operations Officer
Daniel D. Long
SVP, Drug Discovery
Third Rock Ventures V, L.P.
10 percent owner
Peter A. Thompson
Director